To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Metha & Nanos short-stemmed prostheses similar bone remodelling & migration following THA

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
January 2016

Metha & Nanos short-stemmed prostheses similar bone remodelling & migration following THA

Vol: 5| Issue: 1| Number:5| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:2

A prospective randomized radiographic and dual-energy X-ray absorptiometric study of migration and bone remodeling after implantation of two modern short-stemmed femoral prostheses

J Orthop Traumatol. 2015 Sep;16(3):237-43.

Contributing Authors:
V Brinkmann F Radetzki KS Delank D Wohlrab A Zeh

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Fifty patients undergoing total hip arthroplasty, due to severe hip osteoarthritis, were randomized to receive either Metha or Nanos short-stemmed femoral implant. Radiographic and clinical outcomes were evaluated and compared for the two prosthetic designs up to 1 year postoperatively. The results indicated that both prosthesis types showed significant longitudinal migration within the first 3 mo...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue